VF
MGNX icon

Virtu Financial’s MacroGenics MGNX Stock Holding History

Virtu Financial’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-67,758
Closed -$82K – 1836
2025
Q2 		$82K Buy
+67,758
New +$98.3K ﹤0.01% 1063
2023
Q2 		– Sell
-23,116
Closed -$166K – 1828
2023
Q1 		$166K Buy
+23,116
New +$139K 0.02% 812
2020
Q4 		– Sell
-10,034
Closed -$253K – 1649
2020
Q3 		$253K Buy
+10,034
New +$274K 0.04% 506
2019
Q2 		– Sell
-11,427
Closed -$205K – 1697
2019
Q1 		$205K Buy
+11,427
New +$198K 0.01% 997
2018
Q2 		– Sell
-37,377
Closed -$940K – 2304
2018
Q1 		$940K Buy
+37,377
New +$908K 0.05% 382

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial's MGNX Position: Q3 2025 in Review

Virtu Financial sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 67,758 shares — an estimated $82K sold.

Virtu Financial first reported a position in MGNX in Q1 2018 and held it in 5 quarters. The position peaked at $940K in Q1 2018. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

  • Virtu Financial reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 67,758 MacroGenics shares in Q3 2025, an estimated $82K.
  • Virtu Financial first reported a position in MacroGenics in Q1 2018 and held it in 5 quarters.
  • Virtu Financial's MacroGenics position peaked at $940K in Q1 2018.
  • 104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.